论文部分内容阅读
目的:观察左旋卡尼汀(L-Carnitine)对缺血性心脏病心衰患者的临床疗效。方法:40例缺血性心脏病心衰患者(EF<50%),随机分为两组。在常规治疗的基础上,治疗组加用左旋卡尼汀3.0g+10%葡萄糖注射液250ml静点,1次/d,10d为1个疗程。结果:左旋卡尼汀治疗缺血性心衰临床疗效优于对照组,有效率分别是85%和65%。治疗组患者对左旋卡尼汀耐受良好,未见药物相关不良反应。结论:左旋卡尼汀对缺血性心脏病心衰患者心脏功能有改善作用,临床疗效满意,为治疗缺血性心衰患者提供了新的选择。
Objective: To observe the clinical efficacy of L-Carnitine in patients with heart failure of ischemic heart disease. Methods: Forty patients with ischemic heart disease (EF <50%) were randomly divided into two groups. On the basis of routine treatment, the treatment group plus L-carnitine 3.0g + 10% glucose injection 250ml static point, 1 / d, 10d for a course of treatment. Results: L-carnitine treatment of ischemic heart failure clinical efficacy than the control group, the effective rate was 85% and 65%. Patients in the treatment group were well tolerated with L-carnitine and no adverse drug-related reactions were observed. Conclusion: L-carnitine can improve heart function in patients with ischemic heart disease and its clinical curative effect is satisfactory. It provides a new option for the treatment of patients with ischemic heart failure.